The Virology Down Under blog.
Facts, data, info, expert opinion and a reasonable voice on viruses: what they are, how they tick and the illnesses they may cause.
Peramivir, a new intravenous drug, is designed to target both influenza A and B viruses. Developed by US-listed biotech BioCryst Pharmaceuticals, it has been fast-tracked by Chinese FDA.
The US CDC developing a candidate virus seed strain.
No comments:
Post a Comment
Note: only a member of this blog may post a comment.
No comments:
Post a Comment
Note: only a member of this blog may post a comment.